Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone

NCT02880319 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Bone Cancer

Interventions

DRUG: Stereotactic Body Radiation Therapy (SBRT)
DEVICE: Stereotactic Linear Accelerator

Sponsor

Dana-Farber Cancer Institute